AstraZeneca Imfinzi plus chemotherapy approved in China for locally advanced or metastatic biliary tract cancer Ruchika Sharma19 Nov 2023 11:45 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Roche subcutaneous injection of Tecentriq recommended by EU CHMP for multiple cancer types Ruchika Sharma19 Nov 2023 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
Bayer recalls one lot of cancer drug Vitrakvi in US over microbial contamination Ruchika Sharma18 Nov 2023 4:30 PM ISTCustomers who have the recalled lot should immediately stop use of the drug and contact their physician or healthcare provider, the company said.
Truqap plus Faslodex approved in US for advanced HR-positive breast cancer: AstraZeneca Ruchika Sharma18 Nov 2023 2:14 PM ISTCambridge: AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult...
USFDA nod to Pfizer, Astellas Pharma Xtandi for early prostate cancar Ruchika Sharma17 Nov 2023 12:30 PM ISTTokyo: Pfizer Inc. and Astellas Pharma Inc. have announced that the companies have received approval from the U.S. Food and Drug Administration...
AstraZeneca breast cancer drug combination gets USFDA okay Ruchika Sharma17 Nov 2023 11:37 AM ISTTruqap belongs to a class of drugs known as AKT inhibitors and works by targeting the AKT1 gene mutation, which is responsible for growth and...
Diabetes drug for prostate cancer? Columbia study provides clarity Dr. Kamal Kant Kohli16 Nov 2023 8:00 PM ISTIn the years since a 2005 study found that diabetes patients taking metformin had lower rates of cancer, oncologists have been excited by the prospect...
USFDA nod to Bristol Myers Squibb Augtyro for lung cancer Ruchika Sharma16 Nov 2023 5:30 PM ISTAugtyro is designed to minimize interactions that can lead to certain forms of treatment resistance in ROS1-positive metastatic NSCLC patients.
Dabur India's two units dismissed as defendants in hair relaxer lawsuit in US Ruchika Sharma16 Nov 2023 4:30 PM ISTDabur's unit Namaste Laboratories continues to be a defendant along with many other industry players such as L'Oreal, Revlon, Luster Products and...
Add on Docetaxel Improves Survival for Low-PSA Prostate Cancer Patients: JAMA Jacinthlyn Sylvia15 Nov 2023 6:30 PM ISTA recent study published in Journal of American Medical Association suggests that adding docetaxel to standard treatment could significantly improve...
Rznomics enters clinical trial collaboration with Roche to evaluate RZ-001 in combo with anti-PDL1 in liver cancer patients Ruchika Sharma15 Nov 2023 11:30 AM ISTSeongnam: Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, has...
New blood test could offer earlier detection of common deadly cancers Dr. Kamal Kant Kohli14 Nov 2023 4:30 PM ISTMost cancers become deadly by keeping a low profile, causing no symptoms until they're too advanced to treat. Ovarian and gastroesophageal cancers are...
